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Human tyrosinase. partially purified from metastatic malignant melanoma. reacted with 
antiserum prepared against tyrosinase purified from Harding- Passey mouse melanoma 
melanosomes. although the human and mouse tyrosinases were not completely identical 
immunologically. The human tyros in ase showed only one band on disc electrophoresis wh ich 
corresponded in mobilit y to T2 tyrosinase of mouse. 
Since Bloch discovered that dopa was a su b-
strate for melanin fo rmation in hum an pigment 
cells [II, the dopa reaction has been widely used for 
the identification of the melanocyte. It is well 
kn own, however. that this method has some disad · 
vantages. because nonspecific reactions such as 
a Ula-oxidation of dopa may occur. An immuno· 
logic identificat ion method, using antibody against 
tyrosi nase. should be highly speci fic for identifica-
tion of the melanocyte. 
We have previously reported lha\ a soluble 
tyrosi_nase could be purified from the melanosomes 
of Harding- Passey (H-P) mouse mel anoma [21. 
a nd an antiserum aJ!ainst thi s tyrosinase has been 
prepared t3J. This an tiserum reacts with the tyro-
sinase purified from the 8 -16 mouse melanoma 
and from t he bai r follicle of the C-57 black mouse, 
but not with mushroom tyrosinase . 
In this paper we report on the reaction of this 
antibody with partially purified human tyrosi nase. 
MATERiALS Al\ O METH ODS 
Human tyrosinase was obtained from hepatic metas-
tatic nodu les of ma lignant melanoma a t autopsy_ All 
tumor nod ules were dissected as free as possi ble from 
su rrounding tissue. The tumor. weighing about 27 gm. 
was homogenized with a Potter-Elvehjem homogenizer in 
10 vo lumes of 0.25 M sucrose. The homogenate was 
centrifuged at 700 x g for 20 min at ODC. The resul tant 
supernatant fract ion was centrifuged a t tl.OOO x g for 20 
min at O°C. The residue was resuspended and incubated 
with 0.1 % trypsin in 0.1 M phospha te buffer. pH 7.4. al 
37°C for I hr and at 6°C overniv; ht. After incubat.ion . the 
mixture was centr ifuged al 105,000 )( g for 60 min . The 
supernatant was concent rated by ultrafil trat ion on a 
Diano PM 30 membrane (Amicon Corpora-tion ). The 
concentrated solution was chromatogra-phed on a 2.5 x 45 
Man usc ript rece ived September 4, 1975: in re\Tised 
form November 26. 1975; accepted for publication De-
cember 4, 1975. 
Reprint requests to: Dr. N. Ohtaki, Department of 
Dermatology, School of Medicine, Tokyo Medical and 
Dental University. 1·5-45 Yushima. Bunkyo- ku. Tokyo. 
Japan . 
e m column of Sephadex G-lOO superfi ne. eluted wit.h a 
0.01 M potass ium phosphate buffer. pH 7.4 . 
H- P mouse melanoma tyrosinase was purified from 
melanosomes following the method of M iyazaki a nd Seiji 
[2J. Antiserum against the purified tyrosinase of H- P 
mouse melanoma was prepared by the method we have 
previously desc ribed [31 a nd tyrosin ase activities were 
determined as pre\,jollsly repOrted 14 J. 
Lmmunodiffusion analy~is was performed by the 
method of Ouchterlony 151, protein was determined 
according to Lowry et al [6]. ac rylamide gel elect rophore-
sis was carri.ed out according to the method of Davis 171. 
and t he dist r ibution of enzymes was demonstrat.ed as 
described by Burnett et al /8J . Quantitative scans of 
dopa-posit ive bands on the gels were carried out with a 
Fujiox densitomet.er FD-A IV (Japan) at 600 nm . 
RESULTS 
A crylamide gel electrophoresis. Both human 
tyrosinase and H- P mouse melanoma tyros inase 
were subjected to acrylamide gel disc eJetrophore-
sis. Following electrophoresis, each gel was neu -
tralized and stained with L-dopa. The electropho. 
retic pattern of partially purified tyrosinase from 
human melan oma is shown in Figure 1. Only one 
dopa-positive band was observed . This band ex-
hibited slower mobility than that of the purified 
tyros inase from H- P mouse mel anoma melano-
some, and corresponded to the T2 band of mouse 
ty rosinase 181-
Immunodiffusion analvsis (Fig_ 2). Well 1 was 
filled with human tyrosinase. and well 2 with H- P 
ty rosinase. Both wells labeled 3 were filled with 
antiserum against H- P tyrosinase. 
The antiserum and H- P tyrosinase gave a single 
precipitin band. Human tyrosinase also gave a 
single band with the antiserum against mouse 
tyrosinase . These single bands form a part ial union 
that is '-a reaction of incomplete identity." This 
means that there is a serologic relat.ionship be· 
tween the two sou rces of t yrosinase, but not 
complete identity, 
Immunodiffusion analysis to test for int.eract.ion 
of the antiserum with human serum proteins or 
32i 
328 OHTAKI AND MIYAZAKI 
2 
FIG . 1. Disc electrophoresis of H- P mouse melanoma 
tyrosinase (2) and human melanoma tyrosinase (1). Sixty 
mU of each were applied and gels were stained with 
L-dopa. Anode is on the right. 
3 
FIG . 2. Immunodiffusion reaction of H- P tyrosinase 
and human ty rosinase. Wells 3 contained rabbit anti -
serum prepared against H- P ty rosinase (5 /J.l of a I : 15 
di lution with saline); well 2. H- P tyrosinase (5 /J.L 
tyrosinase activity; 38 mUl; and weill. human tyrosinase 
(5 /J.1. tyrosinase activity; 40 mU). After the precipitin li ne 
formed. the plate was incubated in 0.1 M phosphate 
buffer (pH 6.8) containing 0. 1 % L.dopa for 10 min at 
room temperature. The precipitin lines stained dark 
brown . 
human liver tissue extract was also performed. In 
neither case were any precipitin lines observed. 
Th e degree of cross-reaction between human 
tyrosinase and mouse tyrosinase. Aliquots of tyro-
sinases from human and mouse melanoma were 
incubated with various amounts of antiserum. After 
running, gels were stained with L-dopa. The results 
in Figure 3 show the disc electr~phoresis patterns 
obtained using varying amounts of added anti-
serum . The observed diminution of the dopa -
stained band was in proportion to the amount of 
antiserum employed, for both human and mouse 
tyrosinase. Tyrosinase, not combined with anti -
serum. migrated to the accustomed posit ion . On 
t he other hand. antibody-bounded tyrosinase did 
Dot migrate electrophoretically and remained in 
the spacer gel or the upper part of the running gel 
because of the increased molecular volume of the 
complex. The minimum amount of antiserum 
needed to combine with total tyrosinase and for its 
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subsequent retention in the spacer gel was almost 
the same fo r human and mouse tyrosinases. 
The exten t of interaction between the antigen 
and the antibody was determined quantitatively 
by densitometric evaluation of the dopa -stained 
enzyme band migrating into t.he separation gel. 
The data indicated essentially equivalent reac· 
tions. 
DI SCUSSION 
The dopa reaction is usually used for the histo-
chemical study of tyrosinase activity in human 
skin or other tissues, although it has some disad-
vantages. Dopa reaction is not specific for the 
detection of tyrosinase and gives a fal se positive 
reaction in the presence of other oxidative en· 
zymes . Auto-ox idation of dopa takes place in some 
cases. Furthermore, inact.ive tyrosinase and proty-
rosinase cannot be detected by the dopa reaction . 
On the other hand. immunologic methods. includ-
ing radioimmunoassay. immunofluorescence, and 
immunoelectrophoresis. should theoretically per-
mit detection of small amounts of tyrosinase even 
in an inactive or proen zymic form. Furthermore . 
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FIG. 3. Disc elect rophoresis of H- P tyrosinase and 
human tyros inase after incubation with rabbit ant.iserum 
against H- P tyrosinase. Each incubation mixtu re con-
tained 15 /J.l of H-P tyrosinase (activity: 57 mU, 0.034 j.J.g 
of protein) in A. and human tyrosinase (activity: 60 mU. 
3. 1 J.lg of protein) in B. and an increasing: volume of a 
1:120 dilution of anti -H- P ty rosinase rabbit serum plus 
simi larly diluted nonimmunized rabbit serum, in a total 
volume of 30 j.J.1. Protein concentrat.ion of both antise rum 
and nonimmunized control serum was 68 mg/ ml. After a 
BO-min incubation. each mixture was subjected to di sc 
electrophoresis. and each gel was stained with L-dopa for 
tyrosinase activity. Anode is on the right. Gel 1, in· 
cubated without antiserum ; Gel 2, incubated with 5 /J.I of 
diluted antiserum; GeL 3, 7.5 J.ll ; GeL 4, 10 J.ll; Gel .S. 15 J.l1. 
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with an immunologic electron microscopic method 
the site of synthesis of tyrosinase in the melanocyte 
may be clarified . 
In the immunologic methods a most important 
procedure is the pu rification of the antigen. Ideal-
ly , human tyrosinase should be used directly to 
raise t he antiserum. As mentioned in our previous 
paper 13], a considerable mass of tumor would be 
necessary to prepare sufficient human tyrosinase 
to obtain a highly specific antiserum. It is difficult 
to obtain such a large mass of human tumor 
without necrosis and infection . On the other hand, 
we can harvest large amounts of mouse melanoma 
experimentally. We have purified mouse tyrosin-
ase and prepared antiserum against it 12,3]. 
The antigenic cross-reaction of human tyrosin . 
ase with antiserum against mouse tyrosinase has 
been shown in the experiments described above. 
Mouse tyrosinase and human tyrosinase are not 
completely identical immunologically , although 
the minimum amounts of antiserum required to 
completely combine with the mouse t.yrosinase and 
human tyrosinase are almost the same (Fig . 3). It is 
concluded, therefore, that. there is a high degree of 
cross-reaction between this antiserum and human 
tyrosinase. The antiserum against mouse tyrosin-
ase may therefore be of value In histochemical and 
clinicopathologic studies of the human pigmentary 
system and of human pigmentary disorder and 
disease. 
OUT tyrosinase preparation from human malig-
nant melanoma shows only one band on electropho-
resis in acryla mide gel. This was also observed by 
Nishioka (personal communicat ion), Some authors 
have reported that extracts of human metastatic 
malignant melanoma contained two forms of solu -
ble tyrosinase 19,10]. These apparently conflicting 
results may arise from differences in material 
studied . Our studies and those of Nishioka were 
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performed on material obtained at autopsy while 
other authors have used biopsy samples. 
In a previous paper [ll], we stated that the 
difference between the Tl and T2 tyrosinase is 
dependent on their sugar contents. After incuba-
tion with neuraminidase, Tl converted into T2 . 
Autodigestion might have occurred in our studies 
and the native tyrosinase might have been com-
pletely converted to T2 tyrosinase. 
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